Skip to content

Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting

Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01300806
Acronym
SBIRT
Enrollment
210
Registered
2011-02-23
Start date
2010-07-31
Completion date
2013-05-31
Last updated
2013-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Keywords

HIV, harmful substance use

Brief summary

The goal of this research is to assess the impact of the screening, brief intervention, and referral to treatment (SBIRT) intervention strategy for harmful substance use among HIV-positive people.

Detailed description

The specific aims of the study are: 1. To assess the feasibility of conducting SBIRT using (1) a patient self-administered intervention embedded in a web-based Personal Health Record (PHR) compared to (2) a provider-administered SBIRT intervention guided by the Electronic Medical Record (EMR) during clinic appointments. 2. To examine the acceptability of web-based PHRs to conduct and communicate SBIRT compared to EMR-activated SBIRT conducted by clinic staff, from the perspective of the patient and the provider. 3. To assess the impact of SBIRT on risky drug and alcohol use in an HIV/AIDS population and subsequent effects on sexual risk behaviors and antiretroviral therapy (ART) adherence.

Interventions

None listed

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age * confirmed prior HIV+ serostatus * ability to provide informed consent to be a participant over a 6 month period * English or Spanish speaking

Exclusion criteria

Inability to answer questions with interviewer assistance. Not receiving primary care in clinic.

Design outcomes

Primary

MeasureTime frame
reduced substance use among HIV-positive people6 months

Secondary

MeasureTime frame
technological innovation to improve the quality of medical care6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026